NeuroRx Says COVID-19 Drug Improves Survival If Overstretched ICUs Excluded

Will Seek EUA Shortly

 
• By Andrew McConaghie
  
ICU Covid
NeuroRx argues that ICUs overwhelmed by COVID-19 cases should be excluded from the trial - but the US FDA may not agree • Source: Getty Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip